[1]Niu MM, Zhan J, Zhang HQ. Role of HOX genes in tumor genesis and development [J]. Acta Anatomica Sinica, 2014, 45(3):430-436. (in Chinese)
牛苗苗, 战军,张宏权. HOX基因在肿瘤发生发展过程中的作用[J].解剖学报, 2014, 45(3):430-436.
[2]Raman V, Martensen SA, Reisman D, et al. Compromised HOXA5 function can limit p53 expression in human breast tumours [J]. Nature, 2000, 405(6789):974-978.
[3]Chen H, Chung SSukumar S. HOXA5-induced apoptosis in breast cancer cells is mediated by caspases 2 and 8 [J]. Mol Cell Biol, 2004, 24(2):924-935.
[4]Raman V, Tamori A, Vali M, et al. HOXA5 regulates expression of the progesterone receptor [J]. J Biol Chem, 2000, 275(34):26551-26555.
[5]Chen EY, Tan CM, Kou Y, et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool [J]. BMC Bioinformatics, 2013, 14(2):128.
[6]Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources [J]. Nat Protoc, 2009, 4(1):44-57.
[7]Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists [J]. Nucleic Acids Res, 2009, 37(1):1-13.
[8]Cieply B, Farris J, Denvir J, et al. Epithelial-mesenchymal transition and tumor suppression are controlled by a reciprocal feedback loop between ZEB1 and grainyhead-like-2 [J]. Cancer Res, 2013, 73(20):6299-6309.
[9]Raju Bagadi SA, Kaur J, Ralhan R. Establishment and characterisation of two novel breast cancer cell lines [J]. Cell Biol Int, 2008, 32(1):55-65.
[10]Rhoads K, Arderiu G, Charboneau A, et al. A role for Hox A5 in regulating angiogenesis and vascular patterning [J]. Lympha Res Biol, 2005, 3(4):240-252.
[11]Arderiu G, Cuevas I, Chen A, et al. HoxA5 stabilizes adherens junctions via increased Akt1 [J]. Cell Adh Migra, 2007, 1(4):185-195.
[12]Peinado H, Marin F, Cubillo E, et al. Snail and E47 repressors of E-cadherin induce distinct invasive and angiogenic properties in vivo [J]. J Cell Sci, 2004, 117(Pt 13):2827-2839.
[13]Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation [J]. Cell, 2011, 144(5):646-674.
[14]Freund A, Orjalo AV, Desprez PY, et al. Inflammatory networks during cellular senescence: causes and consequences [J]. Trends Mol Med, 2010, 16(5):238-246.
[15]Warburg O. On respiratory impairment in cancer cells [J]. Science, 1956, 124(3215):269-270.
[16]Warburg O. On the origin of cancer cells [J]. Science, 1956, 123(3191):309-314.
[17]Potter VR. The biochemical approach to the cancer problem [J]. Fed Proc, 1958, 17(2):691-697.
[18]Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation [J]. Science, 2009, 324(5930):1029-1033.[19]Jones RG, Thompson CB. Tumor suppressors and cell metabolism: a recipe for cancer growth [J]. Genes Dev, 2009, 23(5):537-548.
[20]DeBerardinis RJ, Lum JJ, Hatzivassiliou G, et al. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation [J]. Cell Metab, 2008, 7(1):11-20.
[21]Allavena P, Germano G, Marchesi F, et al. Chemokines in cancer related inflammation [J]. Exp Cell Res, 2011, 317(5):664-673.
[22]Wooster R, Bachman KE. Catalogue, cause, complexity and cure; the many uses of cancer genome sequence [J]. Curr Opin Genet Dev, 2010, 20(3):336-341.
[23]Wei EK, Wolin KY, Colditz GA. Time course of risk factors in cancer etiology and progression [J]. J Clin Oncol, 2010, 28(26):4052-4057.
[24]Coussens LM, Zitvogel L, Palucka AK. Neutralizing tumor-promoting chronic inflammation: a magic bullet [J]? Science, 2013, 339(6117):286-291. |